WARNING:
JavaScript is turned OFF. None of the links on this concept map will
work until it is reactivated.
If you need help turning JavaScript On, click here.
This Concept Map, created with IHMC CmapTools, has information related to: Breast Cancer Endpoints - Master Primary m7, Neoadjuvant setting has_component Overall Survival (OS), FDA Criteria for Efficacy endpoints for Breast Cancer treatment has_pertinent_information Tumor Biopsy, Main concept groups (e.g. Primary endpoints) are denoted by Larger bold font with thicker outline, Lymph node examination measured_over Quantity of nodes, Adjuvant setting has_component Disease free survival (DFS), Tumor assessment is_derived_from RECIST v1.1 criteria, FDA Criteria for Efficacy endpoints for Breast Cancer treatment has_pertinent_information Cancer stage, Neoadjuvant setting has_component Pathologic complete response (pCR), Target lesion has_component Quantitative assessment, Demographics/Medical history has_components >Age >Ethnicity >Pregnancy status >BRCA1/2 mutation >Gene expression >Co-morbidities, Concepts (e.g. CRF:pCR:Surgical margins are denoted by solid round-edged rectangle, Baseline assessment has_pertinent_information Image acquisition, Lymph node examination include_evaluation_of Size of largest lymph node metasteses, Other lymph nodes include_ evaluation_of Other lymph node dissection, Surgery includes_evaluation_of Breast specimen, Advanced setting has_component Progression free survival (PFS), Repeated concepts/instances are denoted by dotted outline, Disease progression validated_by Tumor assessment, Disease absent is_measured_from Breast tumor microscopic assessment, Pathologic complete response (pCR) assess_components_of Surgery